Faculty profile
James Young
Back to facultyResearch
Read how they describe their research on their McGill University profile.
Latest papers
Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration.
The lancet. HIV · 2023
Latest funding
- $100,000
After the Cure: Measuring the full impacts of direct acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
CIHR · 2022 · Co-investigator
- $1,587,376
After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
CIHR · 2022 · Co-investigator
- $99,800
Evaluating the efficacy of combination Direct Acting Antiviral Agents for HCV in the Real World: Mimicking Randomized Trials with a Bayesian Approach
CIHR · 2015 · Co-investigator
1 publications.
Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration.
Rein SM, Lodi S, Logan RW, Touloumi G, Antoniadou A, Wittkop L, Bonnet F, van Sighem A, van der Valk M, Reiss P, Klein MB, Young J, Jarrin I, d'Arminio Monforte A, Tavelli A, Meyer L, Tran L, Gill MJ, Lang R, Surial B, Haas AD, Justice AC, Rentsch CT, Phillips A, Sabin CA, Miro JM, Trickey A, Ingle SM, Sterne JAC, Hernán MA, Antiretroviral Therapy Cohort Collaboration and the HIV-CAUSAL Collaboration
After the Cure: Measuring the full impacts of direct acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
Principal investigators: Klein, Marina B
Keywords: Access To Care; Co-Infection; Cure; Direct Acting Antivirals; Fibrosis Progression; Health Outcomes; Hepatitis C Virus; Hiv; Prospective Cohort Study; Re-Infection
After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
Principal investigators: Klein, Marina B
Keywords: Access To Care; Co-Infection; Cure; Direct Acting Antivirals; Fibrosis Progression; Health Outcomes; Hepatitis C Virus; Hiv; Prospective Cohort Study; Re-Infection
Evaluating the efficacy of combination Direct Acting Antiviral Agents for HCV in the Real World: Mimicking Randomized Trials with a Bayesian Approach
Principal investigators: Klein, Marina B
Keywords: Bayesian Methods; Direct Acting Antivirals; Efficacy; Hepatitis C Virus; Hiv; Observational Study; Post-Marketing; Trials
Tracking a revolution: Evaluating the impact of modern HCV therapy on HIV-HCV coinfection
Principal investigators: Klein, Marina B
Keywords: Antiviral Treatments; Clinical Trials; Cohort Study; Health Economics; Health Outcomes; Hepatitis C Virus (Hcv); Hiv; Methods; Models Of Care; Vulnerable Populations
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
Frequent collaborators
- Marina Klein and Raynell Lang: 14 shared papers
- Marina Klein and James Young: 1 shared paper
- Raynell Lang and James Young: 1 shared paper
- Epidemiology, Biostatistics and Occupational Health
- Medicine
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.